Over time, as the science continues to evolve and expand, new conditions will be added and new findings relevant to the initial 18 conditions will be incorporated into member profiles to ensure they have the most accurate and up-to-date picture of their genetic predispositions and what they can do to optimize their health.
"Much has been said and written about the potential of putting personal genetic information in the hands of consumers," says Dr. David Agus, Navigenics co-founder, board member and clinical advisory board chair. "We're convinced we've developed a service that maximizes the potential for the latest genetic information to positively impact behavior and accurately inform health decisions -- and in the process improve health across the population, one person at a time."
The company's proposed standards for personal genomic services will
include commitments to 10 specific criteria for performance, service and
1. Validity - of genetic association, epidemiological and clinical
information provided through the service and used to determine
predispositions for included health conditions
2. Accuracy and quality - of testing, with all samples processed in a
reputable CLIA-certified lab and in accordance with state and federal
regulation, with guaranteed analytical accuracy of 99 percent or more,
and with a "100 percent call rate" guarantee
3. Clinical relevance - of information provided, using only genetic risk
factors that show consistent effect sizes in multiple sample
populations of the same ethnicity; with supporting information vetted
by a team of experienced, clinically trained reviewers, and with
content screened or provided by leading medical institutions or
reputable, independent content providers
|SOURCE Navigenics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved